Magnetic resonance angiography in giant cell arteritis: results of a randomized controlled trial of tocilizumab in giant cell arteritis
- 22 February 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 57 (6), 982-986
- https://doi.org/10.1093/rheumatology/key015
Abstract
To analyse magnetic resonance angiographic (MRA) vessel wall signals from a randomized controlled trial of tocilizumab (TCZ) to treat GCA. Participants were assigned in a 2:1 ratio to receive either TCZ + glucocorticoids (GCs) or placebo + GC infusions at 4-week intervals for 52 weeks. GCs were started at 1 mg/kg/day, then tapered to 0.1 mg/kg/day at week 12 and thereafter down to zero. Patients with initial positive MRA findings underwent control MRA at weeks 12 and 52. Vessel wall signals were scored from 0 (normal) to 3 (intense late enhancement). Outcomes were the number of patients with complete MRA remission at weeks 12 and 52, and changes in vasculitis score, vessel anatomy and atherosclerosis. Of the 30 randomized participants, nine TCZ and two placebo patients had no vessel wall enhancement on initial MRA. At week 12, MRAs were performed in nine TCZ and four placebo patients (nine and three in clinical remission, respectively). Three (33%) TCZ patients showed normalization of vessel wall signals compared with one (25%) placebo patient. At week 52, there was additional MRA improvement in some TCZ patients, but one-third showed persistent or increased late vessel wall enhancement. There was no formation of aneurysms or stenosis and no increase in atherosclerosis. Although TCZ resulted in complete clinical and laboratory remission of GCA over 52 weeks, MRA signals in vessel walls normalized in only one-third of patients. Whether these signals are of prognostic importance remains to be determined.Keywords
This publication has 16 references indexed in Scilit:
- Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trialAnnals Of The Rheumatic Diseases, 2013
- Imaging in vasculitisBest Practice & Research Clinical Rheumatology, 2013
- Screening for atherosclerotic plaques in the abdominal aorta in high-risk patients with multicontrast-weighted MRI: a prospective study at 3.0 and 1.5 teslaThe British Journal of Radiology, 2011
- Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta‐analysisArthritis & Rheumatism, 2007
- Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine familyInternational Immunopharmacology, 2005
- Assessment of the cranial involvement pattern of giant cell arteritis with 3t magnetic resonance imagingArthritis & Rheumatism, 2005
- Using MRI to Assess Aortic Wall Thickness in the Multiethnic Study of Atherosclerosis: Distribution by Race, Sex, and AgeAmerican Journal of Roentgenology, 2004
- The epidemiology of biopsy-positive giant cell arteritis: special reference to changes in the age of the populationRheumatology, 2003
- Correlation of interleukin‐6 production and disease activity in polymyalgia rheumatica and giant cell arteritisArthritis & Rheumatism, 1993
- Estimating the Reliability, Systematic Error and Random Error of Interval DataEducational and Psychological Measurement, 1970